Global Generic Drug Market, By Type (Pure Generic, Branded Generic), Indication (Central Nervous System (CNS), Cardiovascular, Dermatology, Oncology, Respiratory Others), Route of Administration (Oral, Topical, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa), Market Trends and Forecast to 2027.
Market Analysis and Insights: Global Generic Drug Market
Global generic drug market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period. Emerging markets and huge investment in research and development are the factors responsible for the growth of this market.
The growth of generic drug market enhanced by the surge of patent expiration of branded drugs and growing cases of chronic diseases. In addition, advances in the formulation such as fixed dose combination and cost-effective treatment are some of the impacting factors for the demand of generic drugs. Nevertheless, product recalls coupled with shortage of drugs are the factors that hinder the growth of this market.
Generic drug is a bioequivalent version of branded drugs which has same strength, dosage, quality, safety, performance and efficacy however it is differ in some extent such as manufacturing process involved in the development of drugs, excipients and packaging. Generic drugs is commercialized when patent of existing banded drugs expire.
Generic drug market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographical expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Global Generic Drug Market Scope and Market Size
Generic drug market is segmented on the basis of type, indication, route of administration end-users and distribution channel.
- On the basis of type, the global generic drug market is segmented into pure generic and branded generic
- Based on indication, the global generic drug market is segmented into central nervous system (CNS), cardiovascular, dermatology, oncology, respiratory and others
- Route of administration segment for global generic drug market is categorized into oral, topical, parenteral and others
- On the basis of end-users, the global generic drug market is segmented into hospitals, homecare, specialty clinics and others
- On the basis of distribution channel, the global generic drug market has been bifurcated into hospital pharmacy, online pharmacy and retail pharmacy
Generic Drug Market Country Level Analysis
Generic drug market is analysed and market size information is provided by country, product type, indication, end-users and distribution channel as referenced above.
The countries covered in the global generic drug market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, in the Asia-Pacific, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.
North America has been witnessing a positive growth owing to the global leaders in research and development activities and established framework of approval process of generic drugs. Europe is considered a second largest growing regional segment owing to the high preference of generic drugs over branded. Asia-Pacific leads the market due to the developing healthcare facilities and rise in government initiatives.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Generic drug market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Generic Drug Market Share Analysis
Generic drug market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to global generic drug market.
The major players covered in the global generic drug market are Pfizer Inc, Teva Pharmaceutical Industries Ltd, Lupin, Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd, ZydusCadila, AurobindoPharma, Cipla Inc., Novartis AG, Wockhardt, Perrigo Company plc, Lannett, Mylan N.V., Amneal Pharmaceuticals LLC, Sun Pharmaceutical Industries Ltd, ApotexInc, Micro Labs Ltd, Bausch health, Torrent Pharmaceuticals Ltd, Endo International plc, Sawai Pharmaceutical Co.,Ltdand Fresenius Kabi AG among others.
Customization Available: Global Generic Drug Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.